United States · Health Care · USD (Thousands) · Annual
Key financials
USD|Thousands
ROE
-426.35%
2021 (actual)
ROA
-200.28%
2021 (actual)
Gross Margin
-
Net Margin
-
Total Assets
$8,335.00K
2021 (actual)
Net Income
-$9,303.00K
2021 (actual)
Valuation
$16,988,060,285.41K
2021 (actual)
Stock Price
$7,770,890.50
2021 (actual)
Historical & projected performance
USD|Thousands
Reported figures and Equlion model projections for the next 5 years.
ROE
+562.7 pt
Company
Sector average
ROA
-234.2 pt
Company
Total Assets
-44.4%
Company
Sector average (own scale)
Net Income
-31,211.3%
Company
Sector average
Valuation
+1,069.8%
Company
Sector average (own scale)
Stock Price
+1,069.8%
Company
Sector average (own scale)
Detailed data
USD|Thousands
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2021. Projections are model estimates, not investment advice.
Want the full financial forecast report for GRI Bio, Inc.? It covers the balance sheet, income statement, cash flow and Equlion model projections.